BioCentury
ARTICLE | Clinical News

AnergiX: ANRG began Phase I testing

July 13, 1998 7:00 AM UTC

Anergen Inc. (ANRG), Redwood City, Calif. Product: AnergiX peptide from cartilage-derived glycoprotein HCgp39 Indication: Treat rheumatoid arthritis Status: ANRG began Phase I testing in patients with...